This inventor holds 1 USPTO granted patent. Top assignee: Celgene Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Boris Seletsky
Introduction
Boris Seletsky is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of MK2 inhibitors. His work has led to the filing of a patent that showcases his innovative approach to addressing medical challenges.
Latest Patents
Boris Seletsky holds a patent for "MK2 INHIBITORS AND USES THEREOF." This patent highlights his expertise in creating compounds that can potentially lead to new therapeutic options for various diseases. He has successfully secured 1 patent that reflects his dedication to advancing medical science.
Career Highlights
Seletsky is currently employed at Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative therapies. His role at Celgene allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to the field.
Collaborations
Throughout his career, Boris has worked alongside notable colleagues such as Xirui Hu and Lixin Qiao. These collaborations have fostered a dynamic environment for innovation and have played a crucial role in the development of new therapeutic strategies.
Conclusion
Boris Seletsky's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of MK2 inhibitors, demonstrate his commitment to improving healthcare outcomes. His career at Celgene Corporation and collaborations with esteemed colleagues further solidify his impact on the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile